CIBC World Market’s Oncolytics Biotech ONCY Stock Holding History
Bought
Maintained
Sold
Other funds holding ONCY
XT
SI
IAIM
CCM
TAM
EFG
PI
CIBC World Market's ONCY Position: Q2 2026 in Review
CIBC World Market increased its Oncolytics Biotech (ONCY) stake by 15% in Q2 2026, buying an estimated $8.35K and bringing the position to 69,303 shares worth $65.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1523.
CIBC World Market first reported a position in ONCY in Q4 2019 and has held it in 27 quarters since. The position peaked at $236K in Q1 2021. 75 funds tracked by Wall St. Rank hold ONCY as of Q2 2026.
- CIBC World Market held 69,303 shares of Oncolytics Biotech worth $65.8K as of Q2 2026.
- CIBC World Market bought 9,000 Oncolytics Biotech shares in Q2 2026, an estimated $8.35K.
- Oncolytics Biotech made up ﹤0.01% of CIBC World Market's portfolio in Q2 2026, its #1523 holding.
- CIBC World Market first reported a position in Oncolytics Biotech in Q4 2019 and has held it in 27 quarters since.
- CIBC World Market's Oncolytics Biotech position peaked at $236K in Q1 2021.
- 75 funds tracked by Wall St. Rank held Oncolytics Biotech as of Q2 2026.
Based on CIBC World Market's 13F filing for Q2 2026, filed 13 Aug 2026.